Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer drug's survivin suppression called into question.

Literature DB >> 22673983

Cancer drug's survivin suppression called into question.

David Holmes.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2012 PMID： 22673983 DOI： 10.1038/nm0612-842b

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 87.241

× No keyword cloud information.

2 in total

1. Antitumor effects of YM155, a novel survivin suppressant, against human aggressive non-Hodgkin lymphoma.

Authors: Aya Kita; Takahito Nakahara; Kentaro Yamanaka; Kenji Nakano; Mari Nakata; Masamichi Mori; Naoki Kaneko; Hiroshi Koutoku; Nobuyuki Izumisawa; Masao Sasamata
Journal: Leuk Res Date: 2011-01-14 Impact factor: 3.715

2. Survivin is a therapeutic target in Merkel cell carcinoma.

Authors: Reety Arora; Masahiro Shuda; Anna Guastafierro; Huichen Feng; Tuna Toptan; Yanis Tolstov; Daniel Normolle; Laura L Vollmer; Andreas Vogt; Alexander Dömling; Jeffrey L Brodsky; Yuan Chang; Patrick S Moore
Journal: Sci Transl Med Date: 2012-05-09 Impact factor: 19.319

2 in total

9 in total

Review 1. MicroRNA regulation and therapeutic targeting of survivin in cancer.

Authors: Jingcao Huang; Hui Lyu; Jianxiang Wang; Bolin Liu
Journal: Am J Cancer Res Date: 2014-12-15 Impact factor: 6.166

Review 2. Monitoring survivin expression in cancer: implications for prognosis and therapy.

Authors: Rodrigo Santa Cruz Guindalini; Maria Cecília Mathias Machado; Bernardo Garicochea
Journal: Mol Diagn Ther Date: 2013-12 Impact factor: 4.074

3. Suppression of Proinflammatory and Prosurvival Biomarkers in Oral Cancer Patients Consuming a Black Raspberry Phytochemical-Rich Troche.

Authors: Thomas J Knobloch; Lana K Uhrig; Dennis K Pearl; Bruce C Casto; Blake M Warner; Steven K Clinton; Christine L Sardo-Molmenti; Jeanette M Ferguson; Brett T Daly; Kenneth Riedl; Steven J Schwartz; Yael Vodovotz; Anthony J Buchta; David E Schuller; Enver Ozer; Amit Agrawal; Christopher M Weghorst
Journal: Cancer Prev Res (Phila) Date: 2015-12-23

4. DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets.

Authors: Corynn Kasap; Olivier Elemento; Tarun M Kapoor
Journal: Nat Chem Biol Date: 2014-06-15 Impact factor: 16.174

5. Hepatocellular carcinoma repression by TNFα-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.

Authors: Dan Li; Jing Fu; Min Du; Haibin Zhang; Lu Li; Jin Cen; Weiyun Li; Xiaotao Chen; Yunfei Lin; Edward M Conway; Eli Pikarsky; Hongyan Wang; Guoyu Pan; Yuan Ji; Hong-Yang Wang; Lijian Hui
Journal: Hepatology Date: 2016-06-11 Impact factor: 17.425

6. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.

Authors: Hui Lyu; Shuiliang Wang; Jingcao Huang; Bolun Wang; Zhimin He; Bolin Liu
Journal: Cancer Lett Date: 2018-01-31 Impact factor: 8.679